AI-assisted films qualify for protection if shaped by human creativity. Pika 2.1, Hailuo, and Bytedance launch new AI video tools.

The US Copyright Office has released new guidance on what protections AI generated art may enjoy, and there aren't many.

He has just finished a shift on-camera and looks the part: A perfect whip of silver hair, a light-blue button-down shirt ... forecast in front of a green screen as news anchor Dia Wall works ...

The company’s AI Subscription Club is expanding to smartphones and its upcoming Ballie robot but may not go further than South Korea. The company’s AI Subscription Club is expanding to ...

Learn more The best dog subscription boxes help take the guesswork ... She also prefers toys that lack additional parts, such as small sewn-on buttons and googly eyes that are easy to swallow.

However, if you have been planning on getting a subscription for the content, you can wait for a while since Apple TV+ has announced a free weekend where you can watch all its content without paying a ...

Real Christmas trees will not be collected from outside people’s homes without a garden bin subscription, some councils have warned. Each council has its own rules for processing and disposing ...

Anthropic has made a deal to settle parts of a copyright infringement lawsuit brought against the maker of the Claude AI model for allegedly distributing protected song lyrics. The agreement ...

College football viewers were dumbfounded when a seemingly obvious call wasn’t made during the playoff game between Texas and Arizona State. Officials then announced that the play was under revi ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025. In this ...

Billionaire Trump surrogate Elon Musk defended his decision to strip critics of their ability to monetize content on X after cracking down on dissent on the social network. Responding to a ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...